Major cardiovascular events and associated factors among routine hemodialysis patients with end-stage renal disease at tertiary care hospital in Somalia

被引:4
作者
Mohamud, Mohamed Farah Yusuf [1 ]
Nur Adan, Faduma [1 ]
Jeele, Mohamed Osman Omar [1 ]
Ahmed, Mohamed A. M. [2 ]
机构
[1] Mogadishu Somali Turkish Training & Res Hosp, Mogadishu, Somalia
[2] Mogadishu Univ, Dept Pediat, Mogadishu, Somalia
关键词
hemodialysis; end-stage renal disease; cardiovascular disease; heart failure; diabetic; hypertension; CHRONIC KIDNEY-DISEASE; COMPLICATIONS; PREDICTOR;
D O I
10.3389/fmed.2023.1086359
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular complications are the most significant cause of death in patients undergoing routine hemodialysi (HD) with end-stage renal disease (ESRD). The main objective of this study is to determine the significant cardiac events and risk factors in patients undergoing routine hemodialysis in Somalia. MethodsWe carried out a cross-sectional retrospective study in a single dialysis center in Somalia. Two hundred out of 224 were included. All of them had ESRD and were on hemodialysis during the study period between May and October 2021. The records of all patients were reviewed, and the following parameters were analyzed socio-demographic factors, risk factors for cardiovascular disease, and the presence of cardiovascular diseases. ResultsThe mean age was 54 +/- 17.5 years (range 18-88 years), and 106 (53%) patients were males. The prevalence of a cardiovascular disease among hemodialysis patients was 29.5%. Moreover, the distribution of cardiovascular diseases was different; heart failure was the most common, about 27.1%, followed by coronary artery disease (17%), pericarditis and pericardial-effusion (13.6%), dysrhythmia (10.2%), cerebrovascular-accident (8.5%), and peripheral vascular disease (3.4%). About 176 (88%) participants had at least one modifiable cardiovascular risk factor. The most common modifiable cardiovascular risk factor was hypertension (n = 45, 25.1%), followed by anemia (n = 28, 15.6%) and diabetes (n = 26, 14.5%). Younger (18-30) participants were six times less likely to have cardiovascular events among hemodialysis than older age 0.4 (0.11-1.12). ConclusionLow prevalence rate of cardiovascular complications was confirmed in ESRD patients receiving hemodialysis in the main HD center in Somalia. Diabetes, anemia, and hypertension were the highest significant risk factors for CVD in HD patients with ESRD in Somalia.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Economic burden of cardiovascular events and fractures among patients with end-stage renal disease
    Doan, Quan V.
    Gleeson, Michelle
    Kim, John
    Borker, Rohit
    Griffiths, Robert
    Dubois, Robert W.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (07) : 1561 - 1569
  • [22] The evaluation of underlyin cardiovascular disease among patients with end-stage renal disease
    Hedayati, SS
    Szczech, LA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 246 - 253
  • [23] Familiality of Cardiovascular Mortality in End-Stage Renal Disease Patients
    Naiman, Natalie
    Cheung, Alfred K.
    Goldfarb-Rumyantzev, Alexander S.
    AMERICAN JOURNAL OF NEPHROLOGY, 2009, 29 (03) : 237 - 243
  • [24] The Evaluation of the Periodontal Status of Hemodialysis Patients with End-Stage Renal Disease
    Dembowska, Elzbieta
    Jaron, Aleksandra
    Raslawska-Socha, Joanna
    Gabrysz-Trybek, Ewa
    Bladowska, Joanna
    Gacek, Szymon
    Trybek, Grzegorz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [25] Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis
    Dembowska, Elzbieta
    Jaron, Aleksandra
    Gabrysz-Trybek, Ewa
    Bladowska, Joanna
    Gacek, Szymon
    Trybek, Grzegorz
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [26] Subdural hematoma in patients with end-stage renal disease receiving hemodialysis
    Wang, I. -K.
    Lin, C. -L.
    Wu, Y. -Y.
    Kuo, H. -L.
    Lin, S. -Y.
    Chang, C. -T.
    Yen, T. -H.
    Chuang, F. -R.
    Cheng, Y. -K.
    Huang, C. -C.
    Sung, F. -C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (06) : 894 - 900
  • [27] Hypertension and Future Cardiovascular Health in Pediatric End-Stage Renal Disease Patients
    Flynn, Joseph T.
    BLOOD PURIFICATION, 2012, 33 (1-3) : 138 - 143
  • [28] Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis, Stefanos
    Roumeliotis, Athanasios
    Dounousi, Evangelia
    Eleftheriadis, Theodoros
    Liakopoulos, Vassilios
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (01) : 77 - 90
  • [29] Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review
    Borow, Kenneth M.
    Mason, R. Preston
    Vijayaraghavan, Krishnaswami
    CARDIORENAL MEDICINE, 2018, 8 (01) : 18 - 30
  • [30] Intensive hemodialysis for cardiomyopathy associated with end-stage renal disease
    Edward Nehus
    Jens Goebel
    Mark Mitsnefes
    Angela Lorts
    Benjamin Laskin
    Pediatric Nephrology, 2011, 26 : 1909 - 1912